High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Elon Musk’s net worth continued to plunge this week as shares of his two flagship companies, Tesla and SpaceX, retreated amid swirling merger speculation, with traders also positioning ahead of SpaceX’s upcoming earnings report. Elon Musk Net Worth is Down...
Mastercard finally closed its acquisition of London-based stablecoin infrastructure provider BVNK on August 3, 2026. If you have ever wondered what happens when the plumbing of global finance decides to move inside the house, this is your answer. It is not just another corporate press release about a strategic partnership; it is the moment the […]
Another SMR stock is expected to make its public debut.
Investors questioned whether combining AstraZeneca with Bristol Myers would strengthen growth enough to justify the financial and regulatory risks.
The Ark Invest founder is betting big on SpaceX.
Suze Orman walked through a real SpaceX IPO trade that turned $10,000 into roughly $5,600 in seven weeks, and her lesson has nothing to do with rockets or Elon Musk.
The Bithumb crypto exchange is preparing for a 2028 initial public offering (IPO) after reorganizing its business and setting out a two-year program to strengthen accounting, compliance and risk controls. South Korea’s largest cryptocurrency exchange said it expects to complete internal-control ...
Apple's Latest Acquisition Signals a Bigger Push Into AI and Advanced Chips
The UK drugmaker is reportedly talking to Bristol Myers Squibb about a nearly $400 billion tie-up, but investors are struggling to diagnose the logic.
The fund holds 80 private companies and focuses on Y Combinator startups, with shares expected to list on the NYSE on August 13
Rocket Lab is rapidly transforming from a launch company into a diversified space business, positioning it for profits and strong free cash flow as early as next year.
As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings report, pay attention to these chart lines.
The FTSE 100 index closed down 10.35 points, 0.1%, at 10,857.70.
One of the largest global pharma companies would be created if a deal were to materialise.
BMY surged roughly 6% in premarket trading on the news before fading; the stock is now trading near flat. The asymmetric price reaction captures the market's immediate verdict: AZN shareholders see a value-destructive deal, while BMY holders see a potential premium exit.
Space Exploration Technologies or SpaceX's (SPCX) current valuation appears attractive after shares
European stock markets closed mostly higher in Monday trading as the Stoxx Europe gained 0.4%, Germa
Also, the e-bike startup spun off from Rivian Automotive Inc., will reportedly begin delivering its first e-bikes next week, ending months of delays that pushed back its original spring launch. The Launch Edition of its $4,500 TM-B e-bike has started...
The company's stock took quite a body blow after it reported first-quarter earnings.
The firm uses AI and machine-learning models to detect signs of coercion or manipulation in digital transactions, helping banks distinguish criminal activity from legitimate ones in real time.
Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.
AstraZeneca stock took a nosedive Monday amid reports it's mulling a mega-merger with Bristol Myers Squibb.
A combination of the two pharmaceutical companies could create an entity valued at nearly $400 billion, according to the Financial Times
Investing.com - U.S. stock index futures advanced on Monday after President Donald Trump said negotiations with Iran were set to begin this week, easing geopolitical concerns that had rattled markets in recent weeks, while technology stocks attempted to extend their recovery following July’s sharp pullback.
SoundHound AI has built something rare in the voice-AI space: a platform that major automakers, restaurant chains, banks, and smart TV brands all depend on. Now, with shares down sharply and a transformative merger pending, several trillion-dollar companies have real reasons to consider writing a check.
SpaceX began trading on June 12, 2026, with an IPO price of $135 per share, giving retail investors an opportunity to buy into one of the world’s most closely watched aerospace companies. A $5,000 investment at the IPO price would have purchased about 37.04 shares. By June 16, those shares had climbed to $225.64, increasing […] The post If You Invested $5K in the SpaceX IPO, How Much Do You Have Now? appeared first on SmartReads by SmartAsset.
The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of Friday’s close, while Bristol Myers Squibb had a total valuation of $133 billion.
SkyWater will continue serving aerospace, defence, and commercial markets while adding IonQ’s quantum technologies.
If maintained until close, the decline would be the stock’s biggest one-day percentage fall since the day of the 2024 U.S. presidential election.
The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.